Partner Benefits
THE BENEFITS OF PARTNERSHIP
We develop meaningful partnerships with organizations that are inclusive and broadly represent our community. Partnerships assure that our programs are culturally competent, representative, equitable, and easily accessible to those searching for information and resources. By joining our program, you are joining a community that shares educational resources, promotes events, advocates for policies, and fosters a supportive hereditary cancer community.
XRAY Syndicated Content
Give your community access to easy to read, expert reviewed articles that are relevant to them. Our XRAY syndicated content tool pulls important information directly onto your site -- with your branding.
Syndicated Research
Give your community access to the latest research, quality of life studies and clinical trials directly from your site - with your branding.
Website Presence ›
Include your logo, mission and a link to your site in our partner directory to help our community learn more and navigate to your resources.
Partner Spotlight ›
Share your initiatives and accomplishments with our community via our partner blogs.
FORCE Partner Testimonials
As siblings and co-founders of HIS Breast Cancer Awareness, we are both breast cancer survivors and carry the BRCA2 genetic mutation. FORCE has played an invaluable role in our lives, both personally and as partners in our mission. The friendships we have built and the support we have received have been instrumental in expanding our reach and deepening our knowledge. FORCE not only keeps us informed about the latest medical breakthroughs but also provides us the opportunity to be part of them! We eagerly anticipate their annual conference, where we can learn more, share our insights, and build new relationships.
Harvey I. Singer, Co-founder
Vicki Singer Wolf, Co-founder
By providing our Spanish-speaking clients with evidence-based studies, relevant topics, and timely updates, the FORCE X-Ray program has delivered content in Spanish, ensuring equitable access to crucial information. This initiative has empowered our clients to better understand cutting-edge cancer research, enabling them to make informed decisions about their health.
Laura A. Logie, PhD, Director of Research
The National LGBTQI+ Cancer Network loves being a partner with FORCE. This partnership not only helps us make sure we have the most updated information on hereditary cancer but has spurred some lovely collaborations that help move both of our focus areas forward.
Scout (he/they), Executive Director, National LGBTQI+ Cancer Network
We have syndicated content from two great offerings by FORCE. We first enrolled in the XRAY program, a few years ago, which helps our callers understand stories that appear in the media. This year we enrolled in Featured Research, which helps our callers understand research studies related to hereditary cancer. It's a great way for us to share the information about clinical trials in a way that is easier for our callers to access than government sites.
Peggy Cottrell | Genetic Program Manager
Sharsheret | The Jewish Breast & Ovarian Cancer Community
At NothingPink, we have a valuable partnership with FORCE, which is enriching for our support group members. Having access to reliable and comprehensive information is crucial, especially for those seeking guidance and support in their journey. FORCE's expertise in hereditary cancer support and research empowers us by providing tools and knowledge to make informed decisions regarding hereditary cancer. This partnership is strengthens the support and resources we provide. We are so grateful to have this partnership to hep make a positive impact in people's lives.
Kelly Kashmer, Executive Director & Founder
www.NothingPink.org, There is nothing "PINK" about breast cancer.
FORCE’s XRAY and syndicated content program make bringing the newest research and learnings to our community easy and reliable. As a partner, we are so grateful for the way that these resources—and all of FORCE’s work— seeks to increase accessibility and overcome barriers to understanding the newest research and clinical trial findings.
Hayley Brown Buxton-Punch, Director of Partnerships and Programs